Rockwell Medical, Inc.

NasdaqCM:RMTI Stock Report

Market Cap: US$144.3m

Rockwell Medical Management

Management criteria checks 2/4

Rockwell Medical's CEO is Mark Strobeck, appointed in Jul 2022, has a tenure of 2.33 years. total yearly compensation is $1.05M, comprised of 53.7% salary and 46.3% bonuses, including company stock and options. directly owns 0.063% of the company’s shares, worth $90.53K. The average tenure of the management team and the board of directors is 2.2 years and 4.4 years respectively.

Key information

Mark Strobeck

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage53.7%
CEO tenure2.3yrs
CEO ownership0.06%
Management average tenure2.2yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

The Market Lifts Rockwell Medical, Inc. (NASDAQ:RMTI) Shares 28% But It Can Do More

Sep 29
The Market Lifts Rockwell Medical, Inc. (NASDAQ:RMTI) Shares 28% But It Can Do More

Rockwell Medical: The Turnaround Is Looking Real

Sep 15

Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Aug 11
Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity

Jul 12
Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity

Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?

May 08
Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?

Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Feb 06
Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Dec 25
Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Oct 11
Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Jun 02
Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

Oct 25
Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Sep 02
An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Rockwell Medical Q2 Earnings Preview

Aug 12

Rockwell Medical: Triferic Remains Key Despite Sluggish Growth Profile

Mar 02

Rockwell Medical: Down But By No Means Out

Oct 05

Rockwell Medical pops 6% on licensing deal for Triferic AVNU in Turkey

Jun 08

Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Mar 08
Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

Feb 10
Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

CEO Compensation Analysis

How has Mark Strobeck's remuneration changed compared to Rockwell Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$1mUS$566k

-US$9m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$978kUS$267k

-US$19m

Compensation vs Market: Mark's total compensation ($USD1.05M) is above average for companies of similar size in the US market ($USD648.89K).

Compensation vs Earnings: Mark's compensation has increased whilst the company is unprofitable.


CEO

Mark Strobeck (53 yo)

2.3yrs

Tenure

US$1,054,169

Compensation

Dr. Mark Strobeck, Ph D., serves as Independent Director at Windtree Therapeutics, Inc. since June 2023 and is its Lead Independent Director since August 13, 2024. He has served as the President, Chief Exe...


Leadership Team

NamePositionTenureCompensationOwnership
Mark Strobeck
President2.3yrsUS$1.05m0.063%
$ 90.5k
Jesse Neri
Senior Vice President of Finance1.1yrsUS$453.18kno data
Megan Timmins
Executive VP3.3yrsUS$660.29k0.036%
$ 51.7k
Timothy Chole
Senior VP & Chief Commercial Officerless than a yearno data0.029%
$ 41.9k
Heather Hunter
Senior VP & Chief Corporate Affairs Officer2.2yrsno datano data

2.2yrs

Average Tenure

51yo

Average Age

Experienced Management: RMTI's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Strobeck
President2.3yrsUS$1.05m0.063%
$ 90.5k
John Cooper
Independent Director7.2yrsUS$142.27k0.11%
$ 161.0k
Robert Radie
Independent Chairman4.7yrsUS$170.00k0.11%
$ 152.1k
Allen Nissenson
Independent Director4.4yrsUS$127.94k0.10%
$ 147.7k
Joan Lau
Independent Director1.1yrsUS$89.51k0.0065%
$ 9.3k
Mark Ravich
Independent Director7.4yrsUS$128.29k0.23%
$ 326.7k
Andrea Smiley
Independent Director3.9yrsUS$130.56k0.10%
$ 145.2k

4.4yrs

Average Tenure

61yo

Average Age

Experienced Board: RMTI's board of directors are considered experienced (4.4 years average tenure).